International conference on the CEA (gene) family : from basic research to clinical applicationTHOMPSON, JOHN A.Tumor biology. 1995, Vol 16, Num 1, issn 1010-4283, 74 p.Conference Proceedings

Carcinoembryonic antigen family members as diagnostic tools in immunohistopathologyWITTEKIND, C.Tumor biology. 1995, Vol 16, Num 1, pp 42-47, issn 1010-4283Conference Paper

Glucuronidation and Methylation of Procyanidin Dimers B2 and 3,3-Di-O-Galloyl-B2 and Corresponding Monomers Epicatechin and 3-O-Galloyl-Epicatechin in Mouse LiverSHRESTHA, Suraj P; THOMPSON, John A; WEMPE, Michael F et al.Pharmaceutical research. 2012, Vol 29, Num 3, pp 856-865, issn 0724-8741, 10 p.Article

Fractionation of high molecular weight tannins in grape seed extract and identification of procyanidin B2-3,3'-di-O-gallate as a major active constituent causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cellsAGARWAL, Chapla; VELURI, Ravikanth; KAUR, Manjinder et al.Carcinogenesis (New York. Print). 2007, Vol 28, Num 7, pp 1478-1484, issn 0143-3334, 7 p.Article

Randomized trial of an allogeneic Melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanomaMITCHELL, Malcolm S; ABRAMS, Judith; JAKOWATZ, James G et al.Journal of clinical oncology. 2007, Vol 25, Num 15, pp 2078-2085, issn 0732-183X, 8 p.Article

Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinomaTANNIR, Nizar M; FORERO-TORRES, Andres; GARTNER, Elaina M et al.Investigational new drugs. 2014, Vol 32, Num 6, pp 1246-1257, issn 0167-6997, 12 p.Article

Inflammatory Enteric Neuropathy With Severe Constipation After Ipilimumab Treatment for Melanoma : A Case ReportBHATIA, Shailender; HUBER, Bertrand R; UPTON, Melissa P et al.Journal of immunotherapy (1997). 2009, Vol 32, Num 2, pp 203-205, issn 1524-9557, 3 p.Article

Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cellsVELURI, Ravikanth; SINGH, Rana P; ZHENGJIE LIU et al.Carcinogenesis (New York. Print). 2006, Vol 27, Num 7, pp 1445-1453, issn 0143-3334, 9 p.Article

Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosisCASSINA, Patricia; PEHAR, Mariana; VARGAS, Marcelo R et al.Journal of neurochemistry. 2005, Vol 93, Num 1, pp 38-46, issn 0022-3042, 9 p.Article

Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibodyFOON, Kenneth A; YANG, Xiao-Dong; THOMPSON, John A et al.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 984-990, issn 0360-3016, 7 p.Conference Paper

Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantationMASOOD, Nehal; RUSSELL, Kenneth J; OLERUD, John E et al.Journal of the American Academy of Dermatology. 2002, Vol 47, Num 1, pp 140-145, issn 0190-9622Article

Acidic fibroblast growth factor attenuates the cytotoxic effects of peroxynitrite in primary human osteoblast precursorsREIFF, Donald A; KELPKE, Stacey; RUE, Loring III et al.The Journal of trauma, injury, infection, and critical care. 2001, Vol 50, Num 3, pp 433-439, issn 1079-6061Conference Paper

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)PATEL, Poulam M; SUCIU, Stefan; BECKER, Juergen et al.European journal of cancer (1990). 2011, Vol 47, Num 10, pp 1476-1483, issn 0959-8049, 8 p.Article

Phase 3 Trial of Everolimus for Metastatic Renal Cell Carcinoma: Final Results and Analysis of Prognostic FactorsMOTZER, Robert J; ESCUDIER, Bernard; KAY, Andrea et al.Cancer. 2010, Vol 116, Num 18, pp 4256-4265, issn 0008-543X, 10 p.Article

Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III StudyAMATO, Robert J; HAWKINS, Robert E; GOONEWARDENA, Madusha et al.Clinical cancer research (Print). 2010, Vol 16, Num 22, pp 5539-5547, issn 1078-0432, 9 p.Article

Immune activation in advanced cancer patients treated with recombinant IL-21 : multianalyte profiling of serum proteinsDODDS, Michael G; FREDERIKSEN, Klaus Stensgaard; SKAK, Kresten et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 6, pp 843-854, issn 0340-7004, 12 p.Article

Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: Impact of HLA class I antigen expression on outcomeSOSMAN, Jeffrey A; UNGER, Joseph M; LIU, P.-Y et al.Journal of clinical oncology. 2002, Vol 20, Num 8, pp 2067-2075, issn 0732-183XArticle

Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/β2-microglobulin DNA-liposome complex, in patients with metastatic melanomaSTOPECK, Alison T; JONES, Amanda; HERSH, Evan M et al.Clinical cancer research. 2001, Vol 7, Num 8, pp 2285-2291, issn 1078-0432Article

Tyrosine kinase receptor activation inhibits NPR-C in lung arterial smooth muscle cellsSUN, Ju-Zhong; OPARIL, Suzanne; LUCCHESI, Pamela et al.American journal of physiology. Lung cellular and molecular physiology. 2001, Vol 25, Num 1, pp L155-L163, issn 1040-0605Article

Ipilimumab in Treatment-naive and Previously Treated Patients with Metastatic Melanoma: Retrospective Analysis of Efficacy and Safety Data from a Phase II TrialTHOMPSON, John A; HAMID, Omid; MINOR, David et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 1, pp 73-77, issn 1524-9557, 5 p.Article

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV MelanomaWEBER, Jeffrey; THOMPSON, John A; SIEGEL, Jonathan et al.Clinical cancer research (Print). 2009, Vol 15, Num 17, pp 5591-5598, issn 1078-0432, 8 p.Article

Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma : results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438)THOMPSON, John A; FISHER, Richard I; LEBLANC, Michael et al.Blood. 2008, Vol 111, Num 8, pp 4048-4054, issn 0006-4971, 7 p.Article

C19orf48 Encodes a Minor Histocompatibility Antigen Recognized by CDB⁺ CytotoxicT Cells from Renal Cell Carcinoma PatientsTYKODI, Scott S; FUJII, Nobuharu; CRESSWELL, Peter et al.Clinical cancer research (Print). 2008, Vol 14, Num 16, pp 5260-5269, issn 1078-0432, 10 p.Article

The absolute bioavailability of oral vinorelbine in patients with solid tumorsLUSH, Richard M; MCCUNE, Jeannine S; TETTEH, Leticia et al.Cancer chemotherapy and pharmacology. 2005, Vol 56, Num 6, pp 578-584, issn 0344-5704, 7 p.Article

Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitroGUOHONG LI; OPARIL, Suzanne; KELPKE, Stacey S et al.Circulation (New York, N.Y.). 2002, Vol 106, Num 7, pp 854-859, issn 0009-7322Article